HDX-MS epitope characterization for evaluating antibody suitability for ELISA-based in vitro potency testing of vaccines
- 20 April 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (11) , 3227-3238
Abstract
ELISA requirements: a crosslinked toxoid presents immune epitopes. Antibodies are screened by hydrogen deuterium exchange. Antibodies targeting separated neutralizing epitopes support in vitro potency testing, replacing in vivo .Keywords
This publication has 82 references indexed in Scilit:
- Epitope screening using Hydrogen/Deuterium Exchange Mass Spectrometry (HDX‐MS): An accelerated workflow for evaluation of lead monoclonal antibodiesBiotechnology Journal, 2021
- The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability StudiesJournal of Pharmaceutical Sciences, 2011
- Common binding site for disialyllactose and tri‐peptide in C‐fragment of tetanus neurotoxinProteins: Structure, Function, and Bioinformatics, 2005
- Approaches to the Control of Acellular Pertussis VaccinesBiologicals, 1999
- Use of ELISA forin vitroPotency Test of Rabies Vaccines for Animal UseBiologicals, 1996
- Crystal Structure of the Pertussis Toxin–ATP Complex: A Molecular SensorJournal of Molecular Biology, 1996
- Tetanus toxin inhibits spontaneous quantal release and cleaves VAMP/synaptobrevinBrain Research, 1995
- Filamentous Hemagglutinin of Bordetella pertussisJournal of Molecular Biology, 1994
- Tetanus toxin action: Inhibition of neurotransmitter release linked to synaptobrevin proteolysisBiochemical and Biophysical Research Communications, 1992
- The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane proteinArchives of Biochemistry and Biophysics, 1983